DK0765313T3 - N,N'-bis (quinolin-4-yl)-diaminderivater, fremstilling deraf og anvendelse deraf som midler mod malaria - Google Patents

N,N'-bis (quinolin-4-yl)-diaminderivater, fremstilling deraf og anvendelse deraf som midler mod malaria

Info

Publication number
DK0765313T3
DK0765313T3 DK95922495T DK95922495T DK0765313T3 DK 0765313 T3 DK0765313 T3 DK 0765313T3 DK 95922495 T DK95922495 T DK 95922495T DK 95922495 T DK95922495 T DK 95922495T DK 0765313 T3 DK0765313 T3 DK 0765313T3
Authority
DK
Denmark
Prior art keywords
diyl
pct
quinolin
bis
phenylene
Prior art date
Application number
DK95922495T
Other languages
Danish (da)
English (en)
Inventor
Werner Hofheinz
Werner Leupin
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK0765313T3 publication Critical patent/DK0765313T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK95922495T 1994-06-17 1995-06-03 N,N'-bis (quinolin-4-yl)-diaminderivater, fremstilling deraf og anvendelse deraf som midler mod malaria DK0765313T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH192894 1994-06-17
PCT/EP1995/002123 WO1995035287A1 (fr) 1994-06-17 1995-06-03 Derives n,n'-bis(quinolin-4-yle)-diamine, leur preparation et leur utilisation en tant qu'antipaludeens

Publications (1)

Publication Number Publication Date
DK0765313T3 true DK0765313T3 (da) 2003-12-08

Family

ID=4221871

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95922495T DK0765313T3 (da) 1994-06-17 1995-06-03 N,N'-bis (quinolin-4-yl)-diaminderivater, fremstilling deraf og anvendelse deraf som midler mod malaria

Country Status (17)

Country Link
US (1) US5736557A (fr)
EP (1) EP0765313B1 (fr)
JP (1) JPH10501540A (fr)
CN (1) CN1120156C (fr)
AT (1) ATE247642T1 (fr)
AU (1) AU691306B2 (fr)
CA (1) CA2192203A1 (fr)
DE (1) DE69531543T2 (fr)
DK (1) DK0765313T3 (fr)
ES (1) ES2204956T3 (fr)
IL (1) IL114099A (fr)
MX (1) MX9606382A (fr)
MY (1) MY115176A (fr)
NZ (1) NZ288223A (fr)
PT (1) PT765313E (fr)
WO (1) WO1995035287A1 (fr)
ZA (1) ZA954796B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9611727A (pt) * 1995-11-16 1999-05-25 Hoffmann La Roche Derivados de quínolina anti-malária
US6174897B1 (en) 1996-10-25 2001-01-16 Bayer Aktiengesellschaft Bis-(quinolyl)-diamines
US5866562A (en) * 1996-10-25 1999-02-02 Bayer Aktiengesellschaft Ring-bridged bis-quinolines
US5882996A (en) * 1997-10-14 1999-03-16 Industrial Technology Research Institute Method of self-aligned dual damascene patterning using developer soluble arc interstitial layer
EP1377554A1 (fr) 1999-06-16 2004-01-07 University Of Iowa Research Foundation Antagonisme des oligonucleotides cpg immunostimulateurs par des 4-aminoquinolines et autres bases faibles
KR100520168B1 (ko) * 1999-06-21 2005-10-10 주식회사 하이닉스반도체 화학증폭형 레지스트에 첨가되는 새로운 페닐렌디아민계 유도체
DE10008522A1 (de) * 2000-02-24 2001-09-06 Hassan Jomaa Verwendung von 2-PHenylendiaminderivaten zur Behandlung von Infektionen
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
WO2003070244A1 (fr) * 2002-02-22 2003-08-28 Abbott Laboratories Antagoniste des effets d'une hormone de concentration de melanine et son utilisation
US6818772B2 (en) 2002-02-22 2004-11-16 Abbott Laboratories Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
WO2007056580A2 (fr) * 2005-11-08 2007-05-18 Pharmadyn, Inc. Procedes et compositions pour traiter des maladies associees a des proteines pathogenes
US8440695B2 (en) * 2005-11-09 2013-05-14 St Jude Children's Research Hospital Use of chloroquine to treat metabolic syndrome
WO2009148659A2 (fr) * 2008-03-05 2009-12-10 Georgetown University Quinoléines antipaludiques et leurs procédés d'utilisation
CA2743903A1 (fr) * 2008-11-18 2010-05-27 The Government Of The United States Of America D.B.A.The Department Of V Eterans Affairs Composes pour traiter une parasitose
EP2470013A4 (fr) * 2009-08-27 2013-05-01 Us Health Composés qui traitent la malaria et empêchent la transmission de la malaria
EP2394981A1 (fr) 2010-06-08 2011-12-14 Lonza Ltd. Procédé de préparation de cis-diaminocycloalkanes
EP2394982A1 (fr) 2010-06-08 2011-12-14 Lonza Ltd. Procédé de préparation de cis-diaminocycloalkanes
CA2802463C (fr) 2010-06-22 2019-02-26 Dna Therapeutics Systeme d'administration in vivo optimise avec des agents endosomolytiques pour des conjugues d'acide nucleique
EP2527440A1 (fr) 2011-05-27 2012-11-28 Institut Curie Traitement du cancer en combinait des molécules d'ADN mimant des ruptures de double brin par hyperthermie
WO2015133280A1 (fr) * 2014-03-03 2015-09-11 公立大学法人名古屋市立大学 Composé ayant une activité antipaludique et médicament antipaludique
KR20170086518A (ko) * 2014-11-25 2017-07-26 바스프 에스이 시스-풍부 mdach 및 트랜스-풍부 mdach의 제조 방법
MA45328A (fr) 2016-04-01 2019-02-06 Avidity Biosciences Llc Compositions acide nucléique-polypeptide et utilisations de celles-ci
KR102313145B1 (ko) * 2016-06-28 2021-10-15 다이니폰 인사츠 가부시키가이샤 화합물, 및 그의 중간체
SG10202107429WA (en) 2017-01-06 2021-08-30 Avidity Biosciences Inc Nucleic acid-polypeptide compositions and methods of inducing exon skipping
GB201711809D0 (en) 2017-07-21 2017-09-06 Governors Of The Univ Of Alberta Antisense oligonucleotide
MX2020003596A (es) 2017-10-04 2020-07-22 Avidity Biosciences Inc Composiciones de acido nucleico-polipeptido y usos de las mismos.
CA3083526A1 (fr) 2017-12-06 2019-06-13 Andrew John Geall Compositions et procedes de traitement de l'atrophie musculaire et de la dystrophie myotonique
SG11202106593UA (en) 2018-12-21 2021-07-29 Avidity Biosciences Inc Anti-transferrin receptor antibodies and uses thereof
KR20210116549A (ko) 2019-01-18 2021-09-27 아스트라제네카 아베 Pcsk9 억제제 및 이의 이용 방법
AU2020287880A1 (en) 2019-06-06 2022-01-20 Avidity Biosciences, Inc. UNA amidites and uses thereof
EP3980436A4 (fr) 2019-06-06 2023-12-20 Avidity Biosciences, Inc. Compositions d'acide nucléique-polypeptide et utilisations de celles-ci
JP2023537798A (ja) 2020-03-19 2023-09-06 アビディティー バイオサイエンシーズ，インク． 顔面肩甲上腕型筋ジストロフィーを処置するための組成物および方法
US11446387B2 (en) 2020-03-27 2022-09-20 Avidity Biosciences, Inc. Compositions and methods of treating muscle dystrophy
EP4251746A1 (fr) 2020-11-30 2023-10-04 Cellectis SA Utilisation de composés d'aminoquinoline pour une intégration de gènes plus élevée
AU2022345098A1 (en) 2021-09-16 2024-04-04 Avidity Biosciences, Inc. Compositions and methods of treating facioscapulohumeral muscular dystrophy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2816893A (en) * 1957-12-17 Improvements in or relating to
US2901484A (en) * 1957-03-04 1959-08-25 Abbott Lab Bis-quinoliniums
US5510356A (en) * 1991-10-03 1996-04-23 University Of Nebraska Board Of Regents Bisquinolines and processes for their production and use to treat malaria

Also Published As

Publication number Publication date
EP0765313A1 (fr) 1997-04-02
AU2736995A (en) 1996-01-15
DE69531543T2 (de) 2004-06-24
IL114099A (en) 2000-02-29
CN1120156C (zh) 2003-09-03
IL114099A0 (en) 1995-10-31
MY115176A (en) 2003-04-30
PT765313E (pt) 2003-11-28
JPH10501540A (ja) 1998-02-10
NZ288223A (en) 1997-11-24
EP0765313B1 (fr) 2003-08-20
ZA954796B (en) 1996-01-03
CA2192203A1 (fr) 1995-12-28
AU691306B2 (en) 1998-05-14
ATE247642T1 (de) 2003-09-15
WO1995035287A1 (fr) 1995-12-28
CN1153513A (zh) 1997-07-02
ES2204956T3 (es) 2004-05-01
MX9606382A (es) 1997-03-29
DE69531543D1 (de) 2003-09-25
US5736557A (en) 1998-04-07

Similar Documents

Publication Publication Date Title
DK0765313T3 (da) N,N'-bis (quinolin-4-yl)-diaminderivater, fremstilling deraf og anvendelse deraf som midler mod malaria
MX9504349A (es) Derivados de aroilpiperidina.
FI943948A0 (fi) Heterosykliset hiilihappojohdannaiset
JO2354B1 (en) New derivatives of aromatic fluoroglycosides and drugs containing these compounds and their use
MY119150A (en) Azetidine derivatives, their preparation and medicaments containing them
DK0579833T3 (da) Ethanolaminderivater med anti-pollakisuria-virkning
CA2134077A1 (fr) 4-imidomethyl-1-[2'phenyl-2'oxoethyl-]piperidines servant de 5ht2-antagonistes de la serotonine, leur mode d'obtention et leur usage therapeutique
ES2191341T3 (es) Derivados de la 2-fenoxianilina.
MX9301701A (es) Derivados de fenotiazina para el tratamiento de la isquema y la hipoxia, composiciones farmaceuticas que los contienen y procedimiento para la preparacion de dichas composiciones farmaceuticas.
DK0678089T3 (da) N-Acylpyrrolidiner og lægemidler til behandling eller forebyggelse af cholecystokinin- og gastrin-relaterede forstyrrelser
ATE181734T1 (de) N-benzoylmethylsubstituierte paroxetinderivate
NO973340L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av fedme
NO952559L (no) N-acyl-pyrrolidiner og medikamenter for behandling eller prevensjon av cholecystokinin- og gastrin-relaterte mangler
ES2099973T3 (es) Derivados de ureido-acetamida su preparacion y los medicamentos que los contienen.
BR9507668A (pt) Intermédio para preparar um composto farmaceuticamente atívo
ES2084485T3 (es) Procedimiento para la preparacion de amino-2 nitro-7 benzotiazoles.
TH51657A (fr)